News from bd (becton, dickinson and company) A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 01, 2019, 16:15 ET BD to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Bank of...


Apr 30, 2019, 06:59 ET BD Receives FDA Approval for Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug...


Apr 29, 2019, 16:15 ET BD Board Declares Dividends

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on June ...


Apr 08, 2019, 06:59 ET BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global availability of BD BACTEC™...


Apr 04, 2019, 16:30 ET BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2019 earnings...


Mar 26, 2019, 06:59 ET BD Launches New Automated Flow Cytometry Sample Preparation Instrument with CE-IVD Certification

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVD certification for the BD...


Mar 21, 2019, 17:25 ET BD Statement on Paclitaxel-Coated Devices

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement related to the...


Mar 14, 2019, 06:59 ET BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration...


Mar 04, 2019, 17:43 ET BD to Present at the Barclays Global Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Barclays...


Feb 15, 2019, 16:30 ET BD to Present at Leerink Partners 8th Annual Global Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at Leerink Partners ...


Feb 05, 2019, 06:00 ET BD Announces Results for 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.160 billion for...


Jan 24, 2019, 06:59 ET BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the U.S. Food and Drug Administration 510(k)...


Jan 21, 2019, 23:01 ET BD Board Declares Dividends

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on...


Jan 17, 2019, 06:00 ET BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported preliminary financial results for the...


Jan 15, 2019, 21:42 ET BD Announces Webcast of Annual Meeting of Shareholders

BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual...


Jan 08, 2019, 16:30 ET BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2019 earnings...


Dec 21, 2018, 16:30 ET BD to Present at Investor Healthcare Conferences

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following...


Dec 20, 2018, 06:59 ET BD Completes Molecular Portfolio for GI Infection With New Viral Panel

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration...


Dec 11, 2018, 06:59 ET BD Announces Completion Of Enterprise Level Cybersecurity Assessment From UL

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level...


Nov 29, 2018, 06:59 ET BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new software application ...


Nov 19, 2018, 16:30 ET BD Board Declares Dividends

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 cents per common share, an...


Nov 13, 2018, 06:59 ET New Diagnostic Test Helps Hospitals More Quickly Identify and Treat Emerging Antibiotic-Resistant Bacteria

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration...


Nov 07, 2018, 12:30 ET BD Announces Clinical Trial Data for the LUTONIX® 014 Drug-Coated Balloon Below-The-Knee IDE Trial

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the safety and efficacy data from the...


Nov 06, 2018, 16:15 ET BD to Present at the Stifel 2018 Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Stifel 2018...


Nov 06, 2018, 06:00 ET BD Announces Results For 2018 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2019 Guidance

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.402 billion for...